Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Are there enough Phase 2 test results to apply for a breakthrough therapy for Covid indications? This board would go nuts if they were awarded a breakthrough designation.
The one person who didn’t approve the merger at 43% interest seems to be the wisest one at this point. However, Rotmans was dead in the water too so... bummer.
The longer the world ignores Leronlimab the more sinister it appears.
Very much so... it’s the only therapeutic that’s working. A local hospital is using the blood plasma from recovered patients and it does help. It’s just not as globally feasible as Leronlimab due to logistics, donors etc.
The UK study is a waste of time, we already know those drugs don’t work well.
The more stock options that are handed out the more traction cydy gets. The world is a very corrupt place even when humans are dying. (See War if you have doubts).
Can lead a horse to water....
Nah, just offer stock options lol
The virus will and has mutated already. It will require seasonal vaccines and they will always be chasing it just like the flu.
Thanks China! - the World
That’s how the game is played
Being in the OTC sucks by the way... way too much Manipulation without institutional investments.
What’s the plan?
I’d be more concerned with bankruptcy of VYST. They had shitty fins before Covid.
Big mistake investing here...
It’s a corrupt world. But there are also 160 other companies all claiming to have the cure just like cydy. Takes time to sort out the riff raff and that’s what we’re considered right now.
We have to have legitimate players on our BOD that have industry links. Small town news footage won’t cut it.
Also, cydy will likely have to start dishing out RS or golden parachutes to power players to get on the stage. You can’t just make it on merit.
11mil volume in two minutes... no price jump. They are absorbing the demand incredible well. If they are shorting it’s a mistake...
Now we’re seeing moves that matter... it’s not what you know it’s who you know. Don’t like it? Get over it, it’s life.
Their loss
The multi indications (as validated by the fda) are remarkable.
profit taking, channel trading and shorting.
Nothing says UK fast track like saving the PMs life. Helps to have friends in high places.
Gilead isn’t testing against a placebo. So they have no baseline. CYDY clinical is a 2:1 controlled, so they have a baseline.
Plus no safety record as you stated. The FDA and Fauci will consider this
Yep, this will continue to plague humans for a long long time. Antibodies don’t last long... look for seasonal vaccines and RNA mutations. It’ll be the new flu. Thanks China!
Then after that look for bird flu to accidentally break out.
I’d bet the world takes remdesivir over leronlimab... not because it’s better but because it’s well known.
If the doctors were savvy they would give both as a cocktail.
It’s a race that CYDY will likely lose because Gilead has better industry influence. Cydy ceo has a clock over his head
Agreed. They haven’t done a clinical study... it’s anecdotal just like leronlimab. However, it’s a big name so it gets the world excited.
It’s a sham. But hey ride the stupid wave where ever it is.
Hilarious
I’d say sell N95 masks... it’s trendy.
https://www.businessinsider.com/fema-paid-bankrupt-company-no-employees-55-million-n95-masks-2020-4
I call dibs on the jumpy house slide
You won’t ... it’s an eind. If you do it’s not worth anything and untrustworthy. Only the clinical means anything
Hardly, I’m guessing you shorted as an amateur and your pro friends covered and left you in the dust.
Hope you didn’t bet the mortgage on it. Good luck
Outside silent, inside empty. - OTC Shell stock.
Perhaps he thinks he can do this on his own... he’s proven he can’t.
Which is why he needs help, he is struggling....
Not worried about others as they don’t have the clean safety signal that leronlimab has. Plus leronlimab has multiple indications.
I’d be more concerned about the leaderships ability to bring to market. File the BLA, get FDA approval for Covid therapeutics. That will be enough to get to Naz requirements.
Well said, and very true
Been there, I’m good on DD. Get to the Naz and this gets easier. It’s called institutional investment
Bingo! Need more power players. Lobbyists count in the big world. Some need to take off the rose colored glasses and realize you don’t win on merit in DC.
Need a CEO with more capacity to make deals with FDA and partners. Sitting on a goldmine doesn’t sell gold.
Get out of the OTC.
Get to the Naz NP
Lol... it’s been tested for many years ... try again
But it does prove that the capacity to produce exists